Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |